Impaired chemosensitivity and perception of dyspnoea in Parkinson's disease

Exacerbation of respiratory failure in Parkinson's disease could be the result of impaired perception of hypoxia. We assessed chemosensitivity to hypoxia and hypercapnia and perception of dyspnoea on the Borg scale in 25 patients (Hoehn and Yahr stage 2–3) and 11 controls. Chemosensitivity to h...

Full description

Saved in:
Bibliographic Details
Published inThe Lancet (British edition) Vol. 356; no. 9231; pp. 739 - 740
Main Authors Onodera, Hiroshi, Okabe, Shinichi, Kikuchi, Yoshihiro, Tsuda, Takehide, Itoyama, Yasuto
Format Journal Article
LanguageEnglish
Published London Elsevier Ltd 26.08.2000
Lancet
Elsevier Limited
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Exacerbation of respiratory failure in Parkinson's disease could be the result of impaired perception of hypoxia. We assessed chemosensitivity to hypoxia and hypercapnia and perception of dyspnoea on the Borg scale in 25 patients (Hoehn and Yahr stage 2–3) and 11 controls. Chemosensitivity to hypoxia, but not that in response to hypercapnia, was lower in patients than in controls (0·196 [SE 0·030] vs 0·525 [0·360]; p=0·012); the mean Borg score was lower in patients than in controls under hypoxic conditions (2·9 [SD 1·4] vs 4·8 [2·1]; p=0·0015). Thus, even at an early stage of disease, patients with Parkinson's disease had a subnormal hypoxic response accompanied by blunted perception of dyspnoea.
Bibliography:SourceType-Other Sources-1
content type line 63
ObjectType-Correspondence-1
ISSN:0140-6736
1474-547X
DOI:10.1016/S0140-6736(00)02638-6